More Medical Articles

Medical

Taking clinical trials to the patient 

Andrew Stone, (Jan 22, 2022)

Putting patients at the center of trials in Japan using new tools and approaches
Medical

The shift towards digital technology for clinical research

Mary Nishikawa, (Dec 21, 2021)

Remote patient participation and trial monitoring can avoid the high risk of hospital visits 
Medical

Pharma’s new leaders in field engagement: MSLs

Andrew Stone, (Nov 30, 2021)

With the whole of pharma in various states of ‘hybridisation’, how can MSLs be supported to deliver enhanced personal service across physical and virtual engagements? 
Medical

Nurturing peer-to-peer interactions in a virtual world  

Lucy Fulford, (Sep 21, 2021)

The serendipitous nature of face-to-face peer interactions is hard to recreate in digital contexts but a focus on small, two-way interactions can yield fruitful peer-to-peer engagement online 
Medical

Transforming cancer care through earlier intervention 

Anonymous (not verified), (Jun 24, 2021)

In our Q&A with Dave Fredrickson, we explore the efforts to continue innovating and bringing better care to cancer patients during and beyond the pandemic
Medical

On the journey from pill to platform

Andrew Stone, (Jun 3, 2021)

For AstraZeneca’s Alex Bedenkov, investing more in post-pandemic medical capabilities is just the start of a far more profound organisation-wide transformation
Medical

From insight to action in medical affairs

Nicola Davies, (May 6, 2021)

Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them
Medical

Redefining the role of the MSL in a changed world

Andrew Stone, (Mar 24, 2021)

MSLs will need to respond to the growing demands being placed on them in the new normal by adopting new approaches, capabilities and skill sets
Access and Evidence

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
Access and Evidence

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Izzy Gladstone, (Feb 11, 2021)

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021

Pages